Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Reducing Alpha-Synuclein in Spinal Cord Injury: A New Strategy of Treatment Publisher Pubmed



Amanat M1 ; Vaccaro AR2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Orthopaedics, Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, PA, United States

Source: Journal of Neuroscience Research Published:2019


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Neurological Conditions Associated With Spinal Cord Injury, Informatics in Medicine Unlocked (2019)
2. Granulocyte Colony-Stimulating Factor (G-Csf) for the Treatment of Spinal Cord Injury, CNS Drugs (2017)
3. Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (Ianr/Canr Version 2019), Journal of Orthopaedic Translation (2020)
4. Non-Coding Rnas and Exosomal Non-Coding Rnas in Traumatic Brain Injury: The Small Player With Big Actions, Molecular Neurobiology (2023)
5. Glitazone in Parkinson's Disease, Movement Disorders (2018)
6. Cellular Therapy for Treatment of Spinal Cord Injury in Zebrafish Model, Molecular Biology Reports (2021)
7. Combined Treatment With Minocycline and Methylprednisolone in Acute Traumatic Spinal Cord Injury: A Pilot Study, Interdisciplinary Neurosurgery: Advanced Techniques and Case Management (2024)
8. Metformin Therapy Attenuates Pro-Inflammatory Microglia by Inhibiting Nf-Κb in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis, Neurotoxicity Research (2021)
Experts (# of related papers)
View all Related Experts
Vafa Rahimi-Movaghar (2)
Iraj Ragerdi Kashani (1)
Other Related Docs
9. Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson’S Disease, Cellular and Molecular Neurobiology (2025)